Flu vaccine campaign about to start In October, many people will receive a new invitation to get the flu vaccine. The flu vaccine protects people who, because of their age or medical condition, are more likely to become ill or seriously ill from flu.
RIVM modelling for COVID-19 reviewed by international experts An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
Reported COVID-19 infections are still rising, but less rapidly The number of reported COVID-19 infections continued increasing last week. However, the number of newly reported infections once again rose less quickly than in the week before that.
Coronavirus measures: public support remains high, despite concerns With the rapid increase in infections, people estimate their own risk of becoming infected as higher than it was 6 weeks ago (previously 10%, now 18%).
Novel coronavirus continues to spread unabated The number of reported cases of COVID-19 continues to rise in all regions and in all age groups. The Municipal Public Health Service (GGD) reported that 43,903 people tested positive for COVID-19 in the past week.
Initial results of rapid antigen tests for COVID-19 very promising Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.
Patient with novel coronavirus COVID-19 in the Netherlands A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.
German coronavirus patient not sick during stay in Limburg On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.